Autres langues Diagonal Bio AB

Actions

DIABIO

SE0015961826

Marché Fermé - Nasdaq Stockholm Autres places de cotation 17:23:34 26/04/2024			Varia. 5j.	Varia. 1 janv.
0,0752 ^SEK	-5,41%		-13,96%	-78,70%

05/04	Diagonal Bio AB (Publ) annonce l'extension de son partenariat avec la Clinique Vétérinaire de Horsholm	CI
05/04	Diagonal Bio AB (Publ) annonce les résultats positifs d'une étude pilote	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Diagonal Bio AB announces outcome of rights issue	24/04
Diagonal Bio AB publish - White paper	16/04
Diagonal Bio AB strengthens its go-to-market strategy through an agreement with founding partner Johan Källstrand	10/04
The subscription period in Diagonal Bio AB rights issue commences today	08/04
Diagonal Bio announces successful pilot study results and extended partnership with Hørsholm Veterinary Clinic	05/04
Diagonal Bio AB Announces the Extension of Its Partnership with Horsholm Veterinary Clinic	05/04
Diagonal Bio AB Announces Successful Pilot Study Results	05/04
Diagonal Bio AB publishes a prospectus because of upcoming rights issue	03/04
Bulletin from the Extraordinary General Meeting on Tuesday 2[nd] of April in Diagonal Bio AB	02/04
Diagonal Bio Makes Interim CEO Permanent	29/02
Diagonal Bio appoints Karin Wehlin as new CEO	28/02
Diagonal Bio Appoints Karin Wehlin as New CEO	28/02
Notice to attend the extraordinary general meeting of Diagonal Bio AB	28/02
The Board of Directors decides on a preferential rights issue of units in order to finance future development	28/02
Diagonal Bio AB Year-end Report 2023	28/02
Diagonal Bio AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28/02
Diagonal Bio Signs Product Distribution Deal With Techtum Lab	16/02
Diagonal Bio AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	31/10/23
Diagonal Bio AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	22/08/23
Diagonal Bio AB announced that it expects to receive SEK 1.8 million in funding	22/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Diagonal Bio AB

Actions

DIABIO

SE0015961826

Autres langues

Filtres